Drug Resistance Updates
Volume 13, Issue 3 , Pages 79-86 , June 2010

Progress in the unraveling of the endoplasmic reticulum stress/autophagy pathway and cancer: Implications for future therapeutic approaches

  • Stephen M. Schleicher
    • ,
  • Luigi Moretti
    • ,
  • Vinod Varki
    • ,
  • Bo Lu

      Affiliations

    • Corresponding Author InformationCorresponding author at: Department of Radiation Oncology, Vanderbilt University, 1301 22nd Avenue South, B-902 TVC, Nashville, TN 37232-5671, United States. Tel.: +1 615 343 9233; fax: +1 615 343 3075.

Received 29 March 2010 ,Accepted 12 April 2010.

References 

  1. Bellodi C, Lidonnici MR, Hamilton A, Helgason GV, Soliera AR, Ronchetti M, et al Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J. Clin. Invest. 2009;119:1109–1123
  2. Bernales S, McDonald KL, Walter P. Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol. 2006;4:E423
  3. Bruserud Ø, Stapnes C, Ersvaer E, Gjertsen BT, Ryningen A. Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cell. Curr. Pharm. Biotechnol. 2007;8:388–400
  4. Cao S, Durrani FA, Rustum YM. Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clin. Cancer Res. 2004;10:2561–2569
  5. Chauhan D, Hideshima T, Mitsiades C, Richardson P, Anderson KC. Proteasome inhibitor therapy in multiple myeloma. Mol. Cancer Ther. 2005;4:686–692
  6. Cook JA, Chuang EY, Tsai MH, Coffin D, Degraff W, Sowers AL, et al. Radiation-induced changes in gene-expression profiles for the SCC VII tumor cells grown in vitro and in vivo. Antioxid. Redox Signal. 2006;8:1263–1272
  7. Daido S, et al. Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res. 2005;65:4368–4375
  8. Devarajan E, Sahin AA, Chen JS, Krishnamurthy RR, Aggarwal N, Brun AM, et al. Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene. 2002;21:8843–8851
  9. Di Bella N, Taetle R, Kolibaba K, Boyd T, Raju R, Barrera D, et al. Results of a phase II study of bortezomib in patients with relapsed or refractory indolent lymphoma. Blood. 2009;115:475–480
  10. Dimopoulos MA, Terpos E. Hematology: first-line bortezomib benefits patients with multiple myeloma. Nat. Rev. Clin. Oncol. 2009;6:683–685
  11. Ding W-X, Yin X-M. Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome. Autophagy. 2008;4:141–150
  12. Ding W-X, Ni H-M, Gao W, Hou Y-F, Melan MA, Chen X, et al. Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J. Biol. Chem. 2007;282:4702–4709
  13. Dowling S, Cox J, Cenedella RJ. Inhibition of fatty acid synthase by Orlistat accelerates gastric tumor cell apoptosis in culture and increases survival rates in gastric tumor bearing mice in vivo. Lipids. 2009;44:489–498
  14. Du K, Herzig S, Kulkarni RN, Montminy M. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science. 2003;300:1574–1577
  15. Fang W, Han A, Bi X, Xiong B, Yang W. Tumor inhibition by sodium selenite is associated with activation of c-Jun NH2-terminal kinase 1 and suppression of beta-catenin signaling. Int. J. Cancer. 2010;
  16. Fels DR, Ye J, Segan AT, Kridel SJ, Spiotto M, Olson M, et al. Preferential cytotoxicity of bortezomib toward hypoxic tumor cells via overactivation of endoplasmic reticulum stress pathways. Cancer Res. 2008;68:9323–9330
  17. Ferrarini M, Heltai S, Zocchi MR, Rugarli C. Unusual expression and localization of heat-shock proteins in human tumor cells. Int. J. Cancer. 1992;51:613–619
  18. Gills JJ, LoPiccolo J, Tsurutani J, Shoemaker RH, Best CJM, Abu-Asab MS, et al. Nelfinavir, a lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulums tress, autophagy, and apoptosis in vitro and in vivo. Clin. Cancer Res. 2007;13:5183–5194
  19. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene. 2004;12:2891–2906
  20. Gozuacik D, Bialik S, Raveh T, Mitou G, Shohat G, Sabanay H, et al. DAP-kinase is a mediator of endoplasmic reticulum stress-induced caspase activation and autophagic cell death. Cell Death Differ. 2008;15:1875–1886
  21. He L, Kim SO, Kwon O, Jeong SJ, Kim MS, Lee HG, et al. FEBS Lett. 2009;583:903–908
  22. Heath-Engel HM, Chang NC, Shore GC. The endoplasmic reticulum in apoptosis and autophagy: role of BCL-2 protein family. Oncogene. 2008;27:6419–6433
  23. Hetz CA. ER stress signaling and the BCL-2 family of proteins: from adaptation to irreversible cellular damage. Antioxid. Redox Signal. 2007;9:2345–2355
  24. Hoang B, Benavides A, Shi Y, Frost P, Lichtenstein A. Effect of autophagy on multiple myeloma cell viability. Mol. Cancer Ther. 2009;8:1974–1984
  25. Høyer-Hansen M, Jäättelä M. Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ. 2007;14:1576–1582
  26. Hwang M, Moretti L, Lu B. HSP90 inhibitors: multi-targeted antitumor effects and novel combinatorial therapeutic approaches in cancer therapy. Curr. Med. Chem. 2009;16:3081–3092
  27. Ishida Y, Yamamoto A, Kitamura A, Lamandé SR, Yoshimori T, Bateman JF, et al. Autophagic elimination of misfolded procollagen aggregates in the endoplasmic reticulum as a means of cell protection. Mol. Biol. Cell. 2009;20:2744–2754
  28. Jaboin J, Hwang M, Lu B. Autophagy in lung cancer. Meth. Enzymol. 2009;453:287–294
  29. Jiang BH, Liu LZ. Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment. Drug Resist. Update. 2008;11:63–76
  30. Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC, et al. A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibition. Nature. 2003;425:407–410
  31. Kawada J, Zou P, Mazitschek R, Bradner JE, Cohen JI. Tubacin kills Epstein-Barr virus (EBV)-Burkitt lymphoma cells by inducing reactive oxygen species and EBV lymphoblastoid cells by inducing apoptosis. J. Biol. Chem. 2009;284:17102–17109
  32. Kawakami T, Inagi R, Takano H, Sato S, Ingelfinger JR, Fujita T, et al. Endoplasmic reticulum stress induces autophagy in renal proximal tubular cells. Nephrol. Dial. Transplant. 2009;24:2665–2672
  33. Kim I, Xu W, Reed JC. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 2008;7:1013–1030
  34. Kim KW, Hwang M, Moretti L, Jaboin JJ, Cha YI, Lu B. Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy. 2008;4:659–668
  35. Kim KW, Moretti L, Lu B. M867, a novel selective inhibitor of caspase-3 enhances cell death and extends tumor growth delay in irradiated lung cancer models. PLoS One. 2008;3:e2275
  36. Kim KW, Moretti L, Mitchell LR, Jung DK, Lu B. Endoplasmic reticulum stress mediates radiation-induced autophagy via PERK-elF2α in caspase-3/7 deficient cells. Oncogene. 2010;
  37. Kimple RJ, Grabowski S, Papez M, Collichio F, Ewend MG, Morris DE. Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme?. Am. J. Clin. Oncol. 2010;
  38. Kouroku Y, Fujita E, Tanida I, Ueno T, Isoai A, Kumagai H, et al. ER stress (PERK/elF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ. 2007;14:230–239
  39. Lee AS, Hendershot LM. ER stress and cancer. Cancer Biol. Ther. 2006;5:721–722
  40. Lee AS. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res. 2007;67:3496–3499
  41. Lee JS, Lee MS, Oh WK, Sul JY. Fatty acid synthase inhibition by amentoflavone induces apoptosis and antiproliferation in human breast cancer cells. Biol. Pharm. Bull. 2009;32:1427–1432
  42. LeFranc F, Facchini V, Kiss R. Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist. 2007;12:1395–1403
  43. Li Y, Zhang T, Schwartz SJ, Sun D. New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential. Drug Resist. Update. 2009;12:17–27
  44. Little JL, Wheeler FB, Fels DR, Joumenis C, Kridel SJ. Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells. Cancer Res. 2007;67:1262–1269
  45. Little JL, Wheeler FB, Koumenis C, Kridel SJ. Disruption of crosstalk between the fatty acid synthesis and proteasome pathways enhances unfolded protein response signaling and cell death. Mol. Cancer Ther. 2008;7:3816–3824
  46. Ma Y, Brewer JW, Diehl JA, Hendershot LM. Two distinct stress signaling pathways converge upon the CHOP promoter during the mammalian unfolded protein response. J. Mol. Biol. 2002;318:1351–1365
  47. Mashima T, Tsuruo T. Defects of the apoptotic pathway as therapeutic target against cancer. Drug Resist. Update. 2005;8:339–343
  48. Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen H-Y, et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell. 2009;137:1062–1075
  49. McConkey DJ, Zhu K. Mechanisms of proteasome inhibitor action and resistance in cancer. Drug Resist. Update. 2008;11:164–179
  50. McLean K, VanDeVen NA, Sorenson DR, Daudi S, Liu JR. The HIV protease inhibitor saquinavir induces endoplasmic reticulum stess, autophagy, and apoptosis in ovarian cancer cells. Gynecol. Oncol. 2009;112:623–630
  51. Micke O, Buntzel J, Kisters K, Schafer U, Micke P, Mucke R. Complementary and alternative medicine in lung cancer patients: a neglected phenomenon?. Front. Radiat. Ther. Oncol. 2010;42:198–205
  52. Micke O, Schomburg L, Buentzel J, Kisters K, Muecke R. Selenium in oncology: from chemistry to clinics. Molecules. 2009;14:3975–3988
  53. Milani M, Rzymski T, Mellow HR, Pike L, Bottini A, Generali D, et al. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with bortezomib. Cancer Res. 2009;69:4415–4423
  54. Misra UK, Deedwania R, Pizzo SV. Activation and cross-talk between Akt, NF-κB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78. J. Biol. Chem. 2006;281:13694–13707
  55. Monini P, Sgadari C, Toschi E, Barillari G, Ensoli B. Antitumour effects of antiretroviral therapy. Nat. Rev. Cancer. 2004;4:861–875
  56. Moretti L, Yang ES, Kwang KW, Lu B. Autophagy signaling in cancer and its potential as novel target to improve cancer therapy. Drug Resist. Update. 2007;10:135–143
  57. Moretti L, Attia A, Kim KW, Lu B. Crosstalk between Bak/Bax and mTOR signaling regulates radiation-induced autophagy. Autophagy. 2007;3:142–144
  58. Moretti L, Cha YI, Niermann KJ, Lu B. Switch between apoptosis and autophagy: radiation-induced endoplasmic reticulum stress?. Cell Cycle. 2007;6:793–798
  59. Moretti L, Kim KW, Jung DK, Willey CD, Lu B. Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor. Mol. Cancer Ther. 2009;8:1270–1279
  60. National Working Group on Neuro-Oncology . Gliomas. Amsterdam, the Netherlands: Association of Comprehensive Cancer Centers (ACCC); 2008;p. 28
  61. Ogata M, Hino S, Saito A, Morikawa K, Kondo S, Kanemoto S. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol. Cell. Biol. 2006;26:9220–9231
  62. Oh S-H, Lim S-C. Endoplasmic reticulum stress-mediated autophagy/apoptosis induced by capsaicin (9-methyl-N-vanillyl-6-nonenamide) and dihydrocapsaicin is regulated by the extent of c-Jun NH2-terminal kinase/extracellular signal-regulated kinase activatin in WI38 lung epithelial fibroblast cells. J. Pharmacol. Exp. Ther. 2009;329:112–122
  63. Okawa Y, Hideshima T, Ikeda H, Raje N, Vallet S, Kiziltepe T, et al. Fatty acid synthase is a novel therapeutic target in multiple myeloma. Br. J. Haematol. 2008;141:659–671
  64. Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, Nedelsky NB, et al HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature. 2007;447:859–863
  65. Park MA, Zhang G, Norris J, Hylemon PB, Fisher PB, Grant S, et al. Regulation of autophagy by ceramide-CD95-PERK signaling. Autophagy. 2008;4:929–931
  66. Pei Z, Li H, Guo Y, Jin Y, Lin D. Sodium selenite inhibits the expression of VEGF, TGFbeta(1) and IL-6 induced by LPS in human PC3 cells via TLR4-NF-(K)B signaling blockage. Int. Immunopharmacol. 2010;10:50–56
  67. Rao RV, Niazi K, Mollahan P, Mao X, Crippen D. Coupling endoplasmic reticulum stress to the cell-death program: a novel HSP90-independent role for the small chaperone protein p23. Cell Death Differ. 2006;13:415–425
  68. Ren Y, Huang F, Liu Y, Yang Y, Jiang Q, Xu C. Autophagy inhibition through PI3K/Akt increases apoptosis by sodium selenite in NB4 cells. BMB Rep. 2009;42:599–604
  69. Salazar M, Carracedo A, Salaneuva IJ, Hernandez-Tiedra S, Lorente M, Egia A, et al. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J. Clin. Invest. 2009;119:1359–1372
  70. Schewe DM, Aguirre-Ghiso JA. Inhibition of elF2α dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy. Cancer Res. 2009;69:1545–1551
  71. Schönthal AH. Endoplasmic reticulum stress and autophagy as targets for cancer therapy. Cancer Lett. 2009;275:163–169
  72. Schröder M. Endoplasmic reticulum stress responses. Cell. Mol. Life Sci. 2008;65:862–894
  73. Selenius M, Rundlöf AK, Olm E, Fernandes AP, Björnstedt M. Selenium and selenoproteins in the treatment and diagnostics of cancer. Antioxid. Redox Signal. 2010;12:867–880
  74. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoom MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New Engl. J. Med. 2005;352:987–996
  75. Todde V, Veenhuis MJ, van der Klei I. Autophagy: principles and significance in health and disease. Biochim. Biophys. Acta. 2009;1972:3–13
  76. Tsukada M, Oshumi Y. Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett. 1993;333:169–174
  77. Vandenabeele P, Berghe TV, Festjens N. Caspase inhibitors promote alternative cell death pathways. Sci. STKE. 2006;358:1–4
  78. Verheij M, Bartelink H. Radiation-induced apoptosis. Cell Tissue Res. 2000;301:133–142
  79. Verheij M, Vens C, van Triest B. Novel therapeutics in combination with radiotherapy to improve cancer treatment: rationale, mechanisms of action and clinical perspective. Drug Resist. Update. 2010;13:29–43
  80. Wu Y, Zhang H, Dong Y, Park YM, Ip C. Endoplasmic reticulum stress signal mediators are targets of selenium action. Cancer Res. 2005;65:9073–9079
  81. Yang Y, Huang F, Ren Y, Xing L, Wu Y, Li Z, et al. The anticancer effects of sodium selenite and selenomethionine on human colorectal carcinoma cell lines in nude mice. Oncol. Res. 2009;18:1–8
  82. Yorimitsu T, Klionsky DJ. Endoplasmic reticulum stress: a new pathway to induce autophagy. Autophagy. 2007;3:160–162
  83. Yorimitsu T, Nair U, Yang Z, Klionsky DJ. Endoplasmic reticulum stress triggers autophagy. J. Biol. Chem. 2006;281:30299–30304
  84. Zhang B, Wang M, Yang Y, Wang Y, Pang Z, Su Y, et al. ERp29 is a radiation-responsive gene in IEC-6 cell. J. Radiat. Res. 2008;49:587–596
  85. Zhao W, Kridel S, Thorbum A, Kooshki M, Little J, Hebbar S, et al. Fatty acid synthase: a novel target for antiglioma therapy. Br. J. Cancer. 2006;95:869–878
  86. Zismanov V, Lishner M, Tartakover-Matalon S, Radnay J, Shapiro H, Drucker L. Tetraspanin-induced death of myeloma cell lines is autophagic and involves increased UPR signaling. Br. J. Cancer. 2009;101:1402–1409

PII: S1368-7646(10)00019-1

doi: 10.1016/j.drup.2010.04.002

Drug Resistance Updates
Volume 13, Issue 3 , Pages 79-86 , June 2010

Article Tools

* Image Usage & Resolution